Full text is available at the source.
Engineered extracellular vesicles and their mimics in cardiovascular diseases
Designed cell particles and similar tools in heart and blood vessel diseases
AI simplified
Abstract
Extracellular vesicles (EVs) may provide new therapeutic options for cardiovascular diseases (CVDs) due to their superior properties.
- CVDs are the leading cause of death globally.
- Current treatments for CVDs face challenges such as low bioavailability and drug resistance.
- EVs are lipid vesicles secreted by cells that are involved in the pathology of CVDs.
- Engineered EVs and EV mimics could address the limitations of traditional pharmacological interventions.
- The review discusses engineering strategies and potential applications of these engineered EVs and EV mimics in treating CVDs.
AI simplified